The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder.
OBJECTIVE
To determine the effectiveness of fluoxetine in alleviating physical symptoms of premenstrual dysphoric disorder.


METHODS
Randomised, double-blind, placebo controlled, parallel study.


METHODS
Canadian University based outpatient clinics. Participants Four hundred and five subjects, of whom 320 with prospectively determined premenstrual dysphoric disorder were randomised.


METHODS
Randomised women were assigned to fluoxetine 20 or 60 mg/day or placebo. Common physical symptoms associated with premenstrual dysphoric disorder including breast tenderness, bloating, and headache were evaluated by visual analog scales and the self-rated and observer premenstrual tension syndrome scales.


METHODS
Luteal phase change from mean baseline scores to mean treatment scores for all scales.


RESULTS
Fluoxetine treatment was statistically superior to placebo, with no significant differences between the two fluoxetine dosages in their effects on physical symptoms.


CONCLUSIONS
Daily fluoxetine treatment is superior to placebo in improving the most common physical symptoms associated with premenstrual dysphoric disorder.
Steiner
M
M
McMaster University, St. Joseph's Hospital, Hamilton, Ontario, Canada.
Romano
S J
SJ
Babcock
S
S
Dillon
J
J
Shuler
C
C
Berger
C
C
Carter
D
D
Reid
R
R
Stewart
D
D
Steinberg
S
S
Judge
R
R
D000328:Adult; D000704:Analysis of Variance; D004311:Double-Blind Method; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage*; D006801:Humans; D011293:Premenstrual Syndrome / Q000188:drug therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage*; D016896:Treatment Outcome
D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors